Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyang Lu

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Acta Pharmaceutica Sinica. B|April 27, 2026
Targeted intestinal barrier repair <i>via</i> probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effectsLi Yu, He Zhang, Chengge Shi, et al.
Heart Rhythm|September 12, 2024
Comparison of acute hemodynamic effect of prioritizing ventricular resynchronization vs left ventricular filling during optimization of cardiac resynchronization therapyYixiu Liang, Ahran D Arnold, Nadine Ali, et al.
European Heart Journal|July 16, 2025
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international studyYixiu Liang, Arunashis Sau, Boroumand Zeidaabadi, et al.
British Journal of Cancer|September 17, 2019
Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective studyYanjun Xu, Zhiyu Huang, Hongyang Lu, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 4, 2026
Electrostatic Potential Tuning by Low-Volatility Halogenated Additive: Boosting PTQ10-Based Binary OPV to Near 20% Efficiency with High ScalabilityHongyang Lu, Jiaxu Che, Lingling Zhan, et al.
Cancer Letters|August 16, 2025
Single-cell profiling identifies biomarkers for immunochemotherapy in esophageal squamous cell carcinomaChangchun Wang, Guanglei Xie, Mingming Jia, et al.
JAMA Oncology|June 26, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical TrialHui Li, Kaiyan Chen, Lei Gong, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Acta Pharmaceutica Sinica. B|April 27, 2026
Targeted intestinal barrier repair <i>via</i> probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effectsLi Yu, He Zhang, Chengge Shi, et al.
Heart Rhythm|September 12, 2024
Comparison of acute hemodynamic effect of prioritizing ventricular resynchronization vs left ventricular filling during optimization of cardiac resynchronization therapyYixiu Liang, Ahran D Arnold, Nadine Ali, et al.
European Heart Journal|July 16, 2025
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international studyYixiu Liang, Arunashis Sau, Boroumand Zeidaabadi, et al.
British Journal of Cancer|September 17, 2019
Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective studyYanjun Xu, Zhiyu Huang, Hongyang Lu, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 4, 2026
Electrostatic Potential Tuning by Low-Volatility Halogenated Additive: Boosting PTQ10-Based Binary OPV to Near 20% Efficiency with High ScalabilityHongyang Lu, Jiaxu Che, Lingling Zhan, et al.
Cancer Letters|August 16, 2025
Single-cell profiling identifies biomarkers for immunochemotherapy in esophageal squamous cell carcinomaChangchun Wang, Guanglei Xie, Mingming Jia, et al.
JAMA Oncology|June 26, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical TrialHui Li, Kaiyan Chen, Lei Gong, et al.
Pageof 13